Buy, Sell... Buy again? 3 stocks worth another look

Selling a stock doesn't mean giving up on it. Two fund managers on the positions they exited, watched fall, and bought back at better value.
Keith Ford

Livewire Markets

“No man ever steps in the same river twice, for it's not the same river and he's not the same man.”

Those are the words of Heraclitus. For the Greek philosopher, it embodied the theory of flux - the idea that change is the fundamental nature of reality. It’s also an apt metaphor for the stock market.

The decision to invest in a stock on any given day is relative to the rest of the market, the company’s underlying fundamentals and a million other variables. Just look at the threat of AI for software companies and how the SaaSpocalypse has played out.

Regardless of whether or not a company was insulated against AI disruption, as Forager portfolio manager Alex Shevelev succinctly puts it: “The sell-off across the technology sector was indiscriminate.”

Investing in one of these hard-hit stocks a year ago was a very different proposition to six months ago. That calculus is once again completely different today.

Yet some investors feel as though walking away from a position is akin to giving up on a company. After all, there was a reason you invested in it to begin with, so if you sold off the entire holding, that conviction must have changed. Reinvesting after that kind of a shift might become a difficult hurdle.

But that doesn’t have to be the case. If you consider the stock market the same way Heraclitus conceptualised the river, then every stock pick is a point-in-time decision.

You’re not investing in the same stock, just as you would not be stepping foot in the same river. The market has moved on and changed, and any investment decisions should be based on the landscape as it is, not how it looked when you exited the stock.

In this wire, I asked Shevelev and Fidelity portfolio manager Maroun Younes about stocks that they had exited before buying back and what changed to make the investment thesis viable again. 

Forager's Alex Shevelev
Forager's Alex Shevelev

Alex Shevelev, Forager

There are two meaningful examples in the Forager Australian Shares Fund: Catapult and Bravura. Both were successful investments that the Fund sold towards the end of 2025 when valuations became less attractive, before buying them again following big share price falls.

Catapult Sports (ASX: CAT)

CAT 1-year chart. Source: Market Index
CAT 1-year chart. Source: Market Index
Catapult is a global leader in technology used by professional sporting teams, including athlete wearables and video analysis. This is a business with high-quality low-churn recurring revenue, growing quickly, with a strong market position globally.

For a professional club spending tens or hundreds of millions of dollars on players, Catapult’s average annual customer spend of roughly US$30,000 per team is relatively immaterial. Yet the technology can help improve performance and reduce injuries, providing a competitive advantage. Its specialist data and integrated hardware and software also make it difficult to replace.

What prompted the sale and in hindsight was it the right decision?

The sale of our Catapult investment was driven purely by valuation. Catapult’s share price rose well above $7 and its market value exceeded $2 billion after it was added to the ASX200. That index inclusion created price-insensitive buying and gave the Fund an attractive opportunity to exit its remaining shares.

Catapult still had a promising future, but the share price was already reflecting a very optimistic outcome. We had barely changed our assessment of the company’s potential during our holding period. 

In hindsight, the decision looks sensible. Catapult’s share price subsequently more than halved from its peaks, allowing us to buy the company back at a much more attractive valuation.

What led to the buy-back?

The sell-off across the technology sector was indiscriminate. Catapult’s products sit inside professional sporting organisations’ workflows. They combine specialist hardware, software, data and industry knowledge, and cost little relative to the value they provide. Following the fall in valuation, we bought back into Catapult. It was the Fund’s second-largest investment by June.

What is the outlook?

The long-term opportunity remains very attractive. Catapult continues to deliver on growth in its core wearables business. After completing a few acquisitions, the business now has more products to cross-sell into its existing clients. And impressive operating leverage has continued.

Bravura Solutions (ASX: BVS)

BVS 1-year chart. Source: Market Index
BVS 1-year chart. Source: Market Index
Bravura provides mission-critical software to wealth managers and superannuation funds. Its systems support essential administration and reporting functions where errors or downtime are unacceptable. Customers rarely turn the software off, and moving to another system can take years.
In the 2023 financial year, Bravura bled $35m of free cash outflow, impaired assets and raised $80 million of capital. Its market value subsequently fell below $150m.

The appointment of Andrew Russell as CEO brought aggressive cost reductions and a clearer focus on the company’s strategy. All the while, Bravura’s high-quality software revenue continued to grow.

What prompted the sale and in hindsight was it the right decision?

The sale of the Fund’s Bravura investment also came down to valuation. The share price rose more than 250% from the Fund’s initial investment as cash generation recovered and the company returned capital to shareholders.

We sold when the valuation became stretched, even as the pace of the turnaround exceeded expectations. In hindsight, this sale also appears well timed. As the wider technology sell-off accelerated, Bravura subsequently nearly halved from its October 2025 high.

What led to the buy-back?

We believe the market has underestimated the difficulty and risk of replacing their deeply embedded financial administration systems. Bravura’s clients operate in regulated industries with little tolerance for system failure. While AI makes software development cheaper, migrating data and workflows to a new provider remains expensive, disruptive and time-consuming. By June, it too had returned to the Fund’s five largest investments.

What is the outlook?

At Bravura, strong demand for project services and further cost-outs have led to continued earnings upgrades. The business is likely to continue to return excess capital to shareholders while looking closely at accretive acquisitions.

Fidelity's Maroun Younes
Fidelity's Maroun Younes

Maroun Younes, Fidelity

We recently re-purchased Arthur J Gallagher (AJG), a Chicago-based global insurance brokerage, risk management and consulting services firm.

We owned the business for several years before exiting the position around 18-24 months ago. Following a pullback in the share price, we have taken the opportunity to re-establish a position.

Arthur J Gallagher (NYSE: AJG)


AJG 1-year chart. Source: TradingView
AJG 1-year chart. Source: TradingView

At an industry level, insurance brokerage is an attractive business because revenue tends to be recurring and relatively resilient to economic cycles. At a company level, AJG has consistently demonstrated its ability to grow organically at rates above GDP while generating strong free cash flow.

The company has also successfully reinvested capital into bolt-on acquisitions that enhance growth and create shareholder value. When we initially purchased the stock, it was trading on a free cash flow yield of around 7%, generating returns on equity in the mid-teens and capable of compounding earnings per share at low double-digit rates over the medium term.

Combined with a modest dividend yield of around 1.5%, we believed the business was well positioned to deliver forecast total shareholder returns in the mid-teens.

What prompted the sale and in hindsight was it the right decision?

Our decision to sell AJG was largely a consequence of its success. The company performed so well that it outgrew our small- and mid-cap investment universe.
While we have some flexibility around the timing of exits, the stock had enjoyed several years of above-average growth and its valuation multiples had expanded significantly. Given those factors, we decided to exit the position.

In hindsight, the decision proved reasonable. Although the share price continued to rise initially after we sold, the insurance cycle subsequently softened, and the stock eventually traded comfortably below our exit price.

What led to the buy-back?

Earlier this year, AJG's share price fell sharply, declining from around US$260 to US$190 per share. Much of the weakness was driven by concerns that AI could disrupt the insurance brokerage industry.
However, our research suggests those fears are overstated. While OpenAI approved the first AI-powered application from an insurance provider, Tuio, its use case relates to home insurance, which is relatively standardised.

AJG, by contrast, predominantly serves corporate and enterprise clients, where insurance needs are far more complex and highly customised. These relationships require specialist advice and tailored solutions, making the business significantly less vulnerable to AI-driven disintermediation.

What is the outlook?

While insurance pricing conditions remain relatively soft, we believe AJG can continue delivering mid-single-digit organic revenue growth despite these headwinds.

The company is also proactively implementing AI across its own operations, which we expect to support productivity gains and margin expansion over time. Together, these factors should enable AJG to compound earnings per share at a mid-teens CAGR over the next two to three years.

Importantly, the stock is currently trading at valuation multiples below its long-term historical averages, which we view as an attractive entry point for a business of this quality, resilience and growth profile.
Managed Fund
Forager Australian Shares Fund
Australian Shares
Managed Fund
Fidelity Global Future Leaders
Global Shares
........
Livewire gives readers access to information and educational content provided by financial services professionals and companies ("Livewire Contributors"). Livewire does not operate under an Australian financial services licence and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any advice given. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs. Before making a decision please consider these and any relevant Product Disclosure Statement. Livewire has commercial relationships with some Livewire Contributors. This article has been prepared without taking into account any person’s objectives, financial situation or needs. It is provided for general information purposes only and is not intended to constitute advice of any kind. References to specific stocks is for illustrative purposes and is not a recommendation to buy, sell or hold those stocks. You should consider the relevant PDS and TMD for any Fidelity Australia product mentioned before making any investment decisions, available at www.fidelity.com.au.

3 stocks mentioned

2 contributors mentioned

Keith Ford
Senior Content Writer & Presenter
Livewire Markets

I’m a Senior Content Writer and Presenter at Livewire Markets, having previously covered the financial advice sector. I have a fundamental belief that taking the time to deeply research a topic drives true understanding, and nowhere is that more...

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment
The 10th annual Livewire Live 2026

One room. One day. The minds that move markets.

22 September 2026 Art Gallery of NSW, Sydney

Register Now